Dr. Michael W. Rich from Washington University School of Medicine in St. Louis, Missouri, told Reuters Health by email, “The main take-home message from this study—and I think it’s an important one—is that the risk of traumatic ICH in older patients experiencing a ground-level fall is low, regardless of whether they are taking antiplatelet agents or oral anticoagulants. Beyond that, I think it’s difficult to draw any firm conclusions about the relative risks with antiplatelet agents vs. oral anticoagulants because the number of traumatic ICHs was low (33), and only four of these patients were taking oral anticoagulants.”
“Although additional study of this important issue is needed, the current study supports the view that in most cases the occurrence of a fall or concern about high risk for falls should not be construed as a sufficient justification for avoiding antiplatelet or anticoagulant therapy when clinically indicated,” said Dr. Rich, who was not involved in the study.
Pages: 1 2 | Single Page
Loading ...
No Responses to “Low Risk of Brain Hemorrhage in Ground-Level Fall with Antiplatelets, Anticoagulants”